South Korea · Delayed Price · Currency is KRW XIIlab Co.,Ltd Statistics
Total Valuation
XIIlab Co.,Ltd has a market cap or net worth of KRW 41.00 billion. The enterprise value is 15.23 billion.
| Market Cap | 41.00B |
| Enterprise Value | 15.23B |
Important Dates
The next estimated earnings date is Thursday, May 14, 2026.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
XIIlab Co.,Ltd has 9.38 million shares outstanding. The number of shares has increased by 20.42% in one year.
| Current Share Class | 9.38M |
| Shares Outstanding | 9.38M |
| Shares Change (YoY) | +20.42% |
| Shares Change (QoQ) | +20.70% |
| Owned by Insiders (%) | 31.52% |
| Owned by Institutions (%) | n/a |
| Float | 6.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.99 |
| PB Ratio | 1.63 |
| P/TBV Ratio | 1.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.88 |
| EV / Sales | 1.48 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -11.14 |
Financial Position
The company has a current ratio of 8.34, with a Debt / Equity ratio of 0.02.
| Current Ratio | 8.34 |
| Quick Ratio | 8.25 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.33 |
| Interest Coverage | -64.67 |
Financial Efficiency
Return on equity (ROE) is -17.96% and return on invested capital (ROIC) is -11.12%.
| Return on Equity (ROE) | -17.96% |
| Return on Assets (ROA) | -9.41% |
| Return on Invested Capital (ROIC) | -11.12% |
| Return on Capital Employed (ROCE) | -12.35% |
| Weighted Average Cost of Capital (WACC) | 9.22% |
| Revenue Per Employee | 160.51M |
| Profits Per Employee | -48.74M |
| Employee Count | 64 |
| Asset Turnover | 0.48 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, XIIlab Co.,Ltd has paid 1.14 million in taxes.
| Income Tax | 1.14M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.55% in the last 52 weeks. The beta is 0.90, so XIIlab Co.,Ltd's price volatility has been similar to the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | -25.55% |
| 50-Day Moving Average | 4,388.90 |
| 200-Day Moving Average | 5,517.53 |
| Relative Strength Index (RSI) | 53.09 |
| Average Volume (20 Days) | 81,136 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, XIIlab Co.,Ltd had revenue of KRW 10.27 billion and -3.12 billion in losses. Loss per share was -425.00.
| Revenue | 10.27B |
| Gross Profit | 2.44B |
| Operating Income | -3.23B |
| Pretax Income | -3.12B |
| Net Income | -3.12B |
| EBITDA | -2.32B |
| EBIT | -3.23B |
| Loss Per Share | -425.00 |
Balance Sheet
The company has 26.23 billion in cash and 454.53 million in debt, with a net cash position of 25.77 billion or 2,746.90 per share.
| Cash & Cash Equivalents | 26.23B |
| Total Debt | 454.53M |
| Net Cash | 25.77B |
| Net Cash Per Share | 2,746.90 |
| Equity (Book Value) | 25.13B |
| Book Value Per Share | 2,678.26 |
| Working Capital | 24.40B |
Cash Flow
In the last 12 months, operating cash flow was -711.99 million and capital expenditures -654.87 million, giving a free cash flow of -1.37 billion.
| Operating Cash Flow | -711.99M |
| Capital Expenditures | -654.87M |
| Depreciation & Amortization | 903.01M |
| Net Borrowing | -645.91M |
| Free Cash Flow | -1.37B |
| FCF Per Share | -145.69 |
Margins
Gross margin is 23.79%, with operating and profit margins of -31.40% and -30.37%.
| Gross Margin | 23.79% |
| Operating Margin | -31.40% |
| Pretax Margin | -30.35% |
| Profit Margin | -30.37% |
| EBITDA Margin | -22.61% |
| EBIT Margin | -31.40% |
| FCF Margin | n/a |
Dividends & Yields
XIIlab Co.,Ltd does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.42% |
| Shareholder Yield | -20.42% |
| Earnings Yield | -7.61% |
| FCF Yield | -3.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 15, 2021. It was a forward split with a ratio of 2.
| Last Split Date | Sep 15, 2021 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
XIIlab Co.,Ltd has an Altman Z-Score of 6.24 and a Piotroski F-Score of 3.
| Altman Z-Score | 6.24 |
| Piotroski F-Score | 3 |